Development of a small molecule inhibitor of PAI-1 for the treatment of diffuse cutaneous systemic sclerosis
Ended Project Grant Awarded Last action
- Award ID
- R44AR074318
- Recipient
-
MDI Therapeutics Inc. UEI T6J4WBXF9EB1
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,493,970
Award facts
- Assistance listing
- 93.846 Arthritis, Musculoskeletal and Skin Diseases Research
- Completion date
- Originally
- Place of performance
- Michigan, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $746,985 | |
| Original award | $746,985 |
Quick answers
Who received award R44AR074318?
R44AR074318 was awarded to MDI Therapeutics Inc. by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on August 1, 2018.
How much is award R44AR074318 worth?
$1,493,970 has been obligated on R44AR074318.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award